Boothbay Fund Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Buy |
+5,000
| New | +$522K | 0.01% | 716 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1230 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1326 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1517 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1578 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1871 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1745 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1942 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1970 |
|
|
2022
Q1 | – | Sell |
-13,447
| Closed | -$508K | – | 1883 |
|
|
2021
Q4 | $508K | Buy |
+13,447
| New | +$508K | 0.01% | 872 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1655 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 834 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 757 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 748 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 676 |
|